CELEX: 62018TA0059
Language: en
Date: 2018-11-22 00:00:00
Title: Case T-59/18: Judgment of the General Court of 22 November 2018 — Endoceutics v EUIPO — Merck (FEMIVIA) (EU trade mark — Opposition proceedings — Application for EU word mark FEMIVIA — Earlier EU word mark FEMIBION INTIMA — Relative ground for refusal — Likelihood of confusion — Article 8(1)(b) of Regulation (EU) 2017/1001)

4.2.2019   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 44/46
            
         
      Judgment of the General Court of 22 November 2018 — Endoceutics v EUIPO — Merck (FEMIVIA)
      (Case T-59/18) (1)
      
      ((EU trade mark - Opposition proceedings - Application for EU word mark FEMIVIA - Earlier EU word mark FEMIBION INTIMA - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EU) 2017/1001))
      (2019/C 44/58)
      Language of the case: English
      
         Parties
      
      
         Applicant: Endoceutics, Inc. (Quebec, Canada) (represented by: M. Wahlin, lawyer)
      
         Defendant: European Union Intellectual Property Office (represented by: A. Lukošiūtė, acting as Agent)
      
         Other party to the proceedings before the Board of Appeal of EUIPO: Merck KGaA (Darmstadt, Germany)
      
         Re:
      
      Action brought against the decision of the Second Board of Appeal of EUIPO of 27 November 2017 (Case R 280/2017-2), relating to opposition proceedings between Merck and Endoceutics.
      
         Operative part of the judgment
      
      The Court:
      
                  1.
               
               
                  Dismisses the action;
               
            
                  2.
               
               
                  Orders Endoceutics, Inc. to pay the costs.
               
            
         (1)  OJ C 112, 26.3.2018.